TEAM
SERVICES
CONTACT
NEWS
More
PATENT PHARMA DAMAGES AFTER AN AT-RISK LAUNCH: A REAL WORLD APPROACH
A lecture at the University of MN College of Pharmacy, presented by Mark S. Robbins on April 11, 201
The Bial 10-2474 Phase 1 Study— A Drug Development Perspective and Recommendations for Future First-
Life Sciences: The isolated human umbilical vein as a bioassay for kinin-generating proteases: An in
Successful Outcome in Contract Litigation
Pharmacological effects of recombinant human tissue kallikrein on bradykinin B2 receptors
Comments